Home > Food & Beverages > Nutraceuticals > Vitamins > Eye Health Ingredients Market

Eye Health Ingredients Market Size

Report ID: GMI1582
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Eye Health Ingredients Market Size

Eye Health Ingredients Market is poised to record more than 7.5% CAGR from 2023-2032, driven by the rising intervention from regulatory bodies, such as the U.S. FDA and EFSA (European Food Safety Authority). The growing intake of eye health supplements is necessitating closer attention to health claims and labeling for ensuring that the products meet the safety and efficacy standards. To cite an example, in August 2023, the FDA issued warnings against the usage of MSM-containing eye drops due to microbial contamination.

To get key market trends

Download Free Sample

Market Growth Drivers & Restraints

The surging awareness about the importance of eye health, primarily driven by the rapidly aging population coupled with the increased screen time and the subsequent rise in digital eye strain and age-related eye conditions will bolster the market growth. However, the dearth of availability of lutein and zeaxanthin coupled with the adverse health effects of carotenoid consumption may limit the industry development.

Authors: Kunal Ahuja, Tushar Malkani

Frequently Asked Questions (FAQ) :

The market size of eye health ingredients is estimated to record more than 7.5% CAGR from 2023 to 2032, driven by the rising intervention from regulatory bodies, such as the U.S. FDA and EFSA (European Food Safety Authority).

Demand for powder eye health ingredients is set to witness over 6.5% CAGR up to 2032, attributed to the growing intake of pharmaceutical drugs worldwide.

APAC eye health ingredients market size is expected to observe over 6.5% CAGR from 2023 to 2032, owing to the rapidly aging population and the growing consumer inclination towards healthy lifestyles in China, Japan and India.

Some of the prominent eye health ingredients market players include Alcon, Amway, MacuShield, Efamol, Swanson Bausch & Lomb, Solgar, BASF, FMC Corporation, Allied Biotech Corporation and DSM.